Solegreen Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Solegreen Ltd with three other
pharmaceutical manufacturers in Middle East:
Oramed Pharmaceuticals Incorporation
sales of 2.47 million Israel Shekels [US$678,921.28 ]
Philadelphia Pharmaceuticals Industry Co PSC
(6.80 million Jordanian Dinars [US$9.61 million]
(2.72 million Israel Shekels [US$749,246.92 ]
of which 100%
was Biological Research).
Solegreen Ltd reported sales of 6.12 million Israel Shekels (US$1.68 million)
December of 2016.
decrease of 0.2%
versus 2015, when the company's sales were 6.13 million Israel Shekels.